TALPHERA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
TALPHERA, INC. (TLPH) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $664.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $664.00K.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $118.00K.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $519.00K.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $226.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value |
|---|---|
| 2026-06-30 | $664.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $118.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $519.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $226.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2024-09-30 | $4.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $5.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.00K 10-K · filed 2024-03-06 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 |
| 2022-12-31 | $0.00 8-K · filed 2023-08-01 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-10 |
| 2020-12-31 | $298.00K 10-K · filed 2021-03-15 |
| 2019-12-31 | $197.00K 10-K · filed 2020-03-16 |
| 2018-12-31 | $659.00K 10-K · filed 2019-03-07 |
| 2017-12-31 | $13.00K 10-K · filed 2018-03-09 |
| 2016-12-31 | $124.00K 10-K · filed 2017-03-03 |
| 2015-12-31 | $1.08M 10-K · filed 2016-03-07 |
| 2014-12-31 | $11.01M 10-K · filed 2015-03-13 |
| 2013-12-31 | $33.32M 10-K · filed 2014-03-17 |
| 2012-12-31 | $3.90M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |